This new drug can be the perfect choice for those who have high cholesterol and a body that does not respond to conventional treatments. In addition to reducing bad cholesterol (LDL), it can counteract arteriosclerosis.

Cholesterol, in addition to triglycerides, are two of the most important indicators for your cardiovascular health. Retaining them at the right levels can help you avoid many of the issues you already know.

Most of us are aware that the word " cholesterol " is almost always associated with something negative. But do not forget that this natural fat is also essential for your body to function.

The key is to keep it in balance and maintain the right levels between the so-called good and bad cholesterol so that it does not accumulate in the arteries.

You probably also know that your genetic background can not only determine the presence of cholesterol, but also your resistance to certain medications that are designed to lower your cholesterol levels.

Even if you take these medications, your lipoproteins can be seated on your artery walls at a dangerous high level . But there is a new treatment that can eliminate this risk.

It's a glimpse of hope, and today we'd like to tell you all about it.

Evolocumab, a new and more effective treatment for high cholesterol
In 2014, a new medical treatment on the market under the name "evolocumab" came to lower cholesterol in humans, which shows no improvements during traditional medical treatment.

From that moment on, detailed investigations were conducted to determine if it could reach the goals expected. The results show that yes the drug is effective. Not only does it manage to reduce "bad" cholesterol, it also counteracts arteriosclerosis.

A new and powerful treatment for cholesterol

In the American College of Cardiology, their study , published how they analyzed the results so far achieved in the treatment of cholesterol with this new drug, evolocumab .

The aim of the treatment was to allow therapeutic intervention for people at high risk of cardiovascular disease and who did not respond to traditional medicine.
The results of the study were very positive. Evolocumab safely and efficiently reduced patients' levels of bad, or LDL, cholesterol.
After 24 weeks of treatment, cholesterol stored in patients' arteries was minimized, so their risk of cardiovascular problems had been significantly reduced.
This drug is already an important therapeutic tool for those who have a genetic background associated with high cholesterol that has already had some form of cardiovascular disease or who can not reduce their cholesterol levels with traditional drugs such as statins.

How does this treatment work?
To effectively lower cholesterol in patients who are resistant to common drugs, it is necessary to combine both treatments.

This new substance is still prescribed together with statins.
Evolocumab acts as a subtilisin obstruction / Kexin convertase protein.
It has been available in a number of countries around the world, with excellent results as a result .

Purpose: Anti-aging anti-corrosion

Atherosclerosis is a slow but deadly disease that stems from plaque deposits (atheromas) that are stored in the arteries.

Atheromer consists not only of cholesterol - they also contain calcium and other substances from the bloodstream.
The biggest problem is that there are no symptoms at the beginning. This is a silent disease that can only be diagnosed through studies.
If it remains undetected, arteriosclerosis can cause problems such as heart attack and stroke.
But another problem for health professionals is, as we said above, that there are many people who simply do not respond to traditional medicine against high cholesterol.
Stephen J. Nichols is the director of the previously mentioned study that demonstrated clear efficacy of evolocumab to treat and antagonize atherosclerosis in all patients.

Their coronary artery scans showed a very positive change after a few months of treatment. Finally, it is possible to reduce the risk of cardiovascular disease to a level that has never been achieved so far.
Who should take this medicine?

Adult patients should follow this treatment if they have already been prescribed the maximum amount of statins and have a cardiovascular disease.

Others include adults with genetic high blood pressure and who already take the maximum dose of statins.
Young people 12 years and older can take this treatment if they have genetic high blood pressure and already take the maximum dose of statins.
All patients in the three previous groups should take this medicine if they also have a particular intolerance to statins.
You must continue the traditional treatments if you pass only the minimum limits for high cholesterol and have no genetic background with this problem.

In any case, do not forget to seek advice from a doctor to take care of your diet and get at least half an hour of exercise every day. High cholesterol is a serious problem that requires too many lives every year.